AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
_6ff029a61766633234293.png?format=webp&width=1186&height=250)
IHH Healthcare Issues 1.8 Million Shares Under Incentive Scheme
ByAinvest
Wednesday, May 28, 2025 3:32 am ET1min read
IHH Healthcare issued 1.8 million shares under an incentive scheme. The Malaysia-based integrated healthcare provider operates in Singapore, Malaysia, India, China, Turkey, and Europe/Southeast Asia through brands such as Acibadem, Mount Elizabeth, and Pantai. The company offers comprehensive care from primary to quaternary levels, as well as ancillary services like lab tests, imaging, and rehabilitation. Its services include day-to-day healthcare, specialist consultations, and local surgeries.
Malaysia-based integrated healthcare provider IHH Healthcare Berhad has announced a significant share issuance under its Enterprise Option Scheme (EOS). On 21 May 2025, the company detailed a series of corporate proposals involving the issuance of shares, with a total of 1,800,000 shares issued as a result of options exercised from various EOS grants spanning from 2016 to 2023 [1].The breakdown of the share issuance includes:
- 11,000 shares issued at MYR 6.5500 for the 2016 grant
- 80,000 shares issued at MYR 6.0200 for the 2018 grant
- 71,000 shares issued at MYR 5.7900 for the 2019 grant
- 140,000 shares issued at MYR 5.9200 for the 2022 grant
- 178,000 shares issued at MYR 5.8700 for the 2023 grant
The latest issued share capital stands at MYR 20,107,767,251.820, with a total of 8,822,484,463 units. The listing date for these shares is set for 22 May 2025 [1].
This strategic move is part of IHH's ongoing efforts to enhance its capital structure and provide incentives to its employees through the EOS. The company aims to remain competitive in the healthcare sector by leveraging its extensive network of brands, including Acibadem, Mount Elizabeth, and Pantai, which operate in Singapore, Malaysia, India, China, Turkey, and Europe/Southeast Asia [1].
The recent share issuance follows a series of insider transactions, including acquisitions and disposals by the Employees Provident Fund Board, a substantial shareholder. These transactions highlight the active participation of key stakeholders in the company's capital management [1].
References:
[1] https://boston2.i3investor.com/web/announcement/detail/1962165
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet